Authors


Lynda Charters; Reviewed by Ursula Schmidt-Erfurth, MD

Latest:

Zooming in on geographic atrophy with OCT-based AI

New analysis brings disease progression and therapeutics into focus


By Lynda Charters; reviewed by Giovanni Montesano, MD

Latest:

Six-year findings from laser in glaucoma and ocular hypertension (LiGHT)

In visual field progression results, SLT was superior to ocular drops as first-line treatment for patients with glaucoma




Adam M. Katz, MD

Latest:

Letter to the Editor: Intravitreal injections. Who should perform them?

In response to a previously published article, three ophthalmologists present their views on intravitreal pharmacotherapy injections.



Dr Claudia Priglinger

Latest:

First-ever retinal gene therapy: Does real-world experience back its use?

Recent reports of retinal atrophy have raised concerns on potential long-term safety.





Dr Dagny Zhu

Latest:

Short-term corticosteroid use can provide rapid relief of allergy symptoms in dry eye disease

A short course of a low-dose corticosteroid eye drop can relieve inflammation with only a low increase in intraocular pressure.




Prof Paolo Vinciguerra

Latest:

Distorted corneas: How to regularise them with minimally invasive surgery

Sequential customised therapeutic keratectomy (SCTK) improves visual quality by eliminating superficial corneal high order aberrations


Ben Shaberman

Latest:

Gene therapy research ushers in new therapy options for retinal diseases

Foundation Fighting Blindness is a driving force in advancing retinal gene therapies into clinical trials.


Professor Winifred Amoaku

Latest:

Risks and management of diabetic retinopathy in paediatric patients

Diabetes mellitus, which is a common chronic disease in children, can lead to significant eye morbidities with long-lasting effects, including diabetic retinopathy. Treatment should be tailored to the individual patient.


Dr Panayiota Founti

Latest:

The impact of landmark studies on clinical practice in glaucoma

Landmark randomised controlled trials have advanced the understanding and treatment of glaucoma.


Dr Paulina Ocieczek

Latest:

Landscape of genetic therapies for USH2A-related retinitis pigmentosa

Increasing understanding of the genetics behind Usher syndrome suggests that treatment may become possible in the very near future.


Dr Livia Faes

Latest:

Assessing barriers to retinal care during a pandemic

A global survey of retinal experts assessed their perceptions of evolving clinical practice in the Covid-19 era, focusing on digital teleophthalmology, home monitoring and decentralised patient care.




Joshua P. Harvey, MA, BM BCh, Pg Cert, FRCOphth

Latest:

The ins and outs of gene therapy for inherited optic neuropathies

A look at what’s in the therapeutic delivery pipeline for these disorders.


Mile Brujic, OD, FAAO

Latest:

Shining new light on ocular surface care

Low-level light therapy for dry eye disease and chalazion


Faruk Semiz, MD

Latest:

Keratoconus: Intrastromal implantation of fresh human lenticules

Stromal regeneration seems possible in patients with keratoconus.


Jai G. Parekh, MD, MBA, FAAO

Latest:

Paying attention to ocular surface disease preoperatively matters

Look for fluctuating vision, test objectively and keep a few effective tools at your disposal to treat OSD.


By Hattie Hayes; Reviewed by Anat Loewenstein, MD

Latest:

The “fourth dimension” of home monitoring

A longitudinal, AI-based approach to fluid quantification


Dr Vanita Berry, Prof. Roy A. Quinlan and Prof. Michel Michaelides

Latest:

Understanding the molecular mechanisms underlying cataract development

A greater understanding of lens embryology and the phenotype/genotype correlation of cataracts should help guide future therapeutic approaches.


Dr Brett Mueller

Latest:

For younger patients with mid-range myopia, consider phakic IOLs

The implantable lenses can offer an advantage over laser surgery


Prof. Navid Ardjomand

Latest:

How to use topography-guided laser procedures to treat keratoconus

Topography-guided PRK, with or without the addition of corneal crosslinking, can improve visual acuity and quality in patients with keratoconus.


Dr Victor A. Augustin
Dr Victor A. Augustin

Latest:

Artificial DMEK could help tackle endothelial donor tissue shortage

Newly developed acrylic implant provides option for patients with endothelial dysfunction.

© 2025 MJH Life Sciences

All rights reserved.